Basic Information
| RNALocate ID: | RLID:11002000 |
| RNA Symbol: | hsa-miR-320a-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-320a |
| RNA ID: | miRBase:MIMAT0000510 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 27278097 |
| Tissue/Cell Line: | Pooled sera |
| Method: | miRNA array |
| Condition: | Acute rejection (AR)|Bronchiolitis obliterans syndrome (BOS)|Stable |
| Description: | Exosomes were defined by flow cytometry for CD63 and western blotting for annexin V SAgs, collagen V (Col-V) and Kα1 tubulin were examined by electron microscopy; miRNAs were profiled by a miRNA array. The global miRNA analysis demonstrated 123 detectable miRNAs (i.e., at least 1 pool with positive detection signal) in sera exosomes. Of these, 15 miRNAs were higher and 108 miRNAs were lower in AR LTxRs compared to stable LTxRs (Table S1). In contrast, 44 miRNAs were higher and 79 miRNAs were lower in BOS LTxRs compared to stable LTxRs (Table S1). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001858 | Cytoplasm | Cardiomyocytes | 31837603 |
| RLID:01001859 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001860 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001861 | Mitochondrion | HEK-293 cells|HeLa cells | 27396686 |
| RLID:01001862 | Mitochondrion | HEK-293 cells|HeLa cells | 27563705 |
| RLID:01001863 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001864 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001865 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001866 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001867 | Nucleus | Cardiomyocytes | 31837603 |
| RLID:01001868 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001869 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11001998 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001999 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11002001 | Exosome | Serum | 18589210 |
| RLID:11002002 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11002003 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002004 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11002005 | Exosome | Brain tissue | 23382797 |
| RLID:11002006 | Exosome | Plasma | 23663360 |
| RLID:11002007 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002008 | Exosome | Serum | 25135963 |
| RLID:11002009 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11002010 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11002011 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11002012 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002013 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11002014 | Microvesicle | Plasma | 23077538 |
| RLID:11002015 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002016 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11002017 | Microvesicle | Serum | 24797360 |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-320a-3p | Cardiomyopathy | MNDR-E-MI-39294 |
| MNDR | hsa-miR-320a-3p | Diffuse large b cell lymphoma | MNDR-E-MI-39295 |
| MNDR | hsa-miR-320a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-39296 |
| MNDR | hsa-miR-320a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-39297 |
| MNDR | hsa-miR-320a-3p | Follicular lymphoma | MNDR-E-MI-39298 |
| MNDR | hsa-miR-320a-3p | Medulloblastoma | MNDR-E-MI-39299 |
| MNDR | hsa-miR-320a-3p | Lymphoma | MNDR-E-MI-39300 |
| MNDR | hsa-miR-320a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-39301 |
| MNDR | hsa-miR-320a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-39302 |
| MNDR | hsa-miR-320a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-39303 |
| MNDR | hsa-miR-320a-3p | Breast cancer luminal | MNDR-E-MI-39304 |
| MNDR | hsa-miR-320a-3p | Lupus nephritis | MNDR-E-MI-39305 |
| MNDR | hsa-miR-320a-3p | Prostate cancer | MNDR-E-MI-39306 |
| MNDR | hsa-miR-320a-3p | Alzheimer disease | MNDR-E-MI-39307 |
| MNDR | hsa-miR-320a-3p | Sickle cell anemia | MNDR-E-MI-39308 |
| MNDR | hsa-miR-320a-3p | Ataxia telangiectasia | MNDR-E-MI-39309 |
| MNDR | hsa-miR-320a-3p | Lung cancer | MNDR-E-MI-39310 |
| MNDR | hsa-miR-320a-3p | Parkinson disease | MNDR-E-MI-39311 |
| MNDR | hsa-miR-320a-3p | Breast cancer | MNDR-E-MI-39312 |
| MNDR | hsa-miR-320a-3p | Pituitary neoplasms | MNDR-E-MI-39313 |
| MNDR | hsa-miR-320a-3p | Pancreatic cancer | MNDR-E-MI-39314 |
| MNDR | hsa-miR-320a-3p | Melanoma | MNDR-E-MI-39315 |
| MNDR | hsa-miR-320a-3p | Wilms tumor | MNDR-E-MI-39316 |
| MNDR | hsa-miR-320a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39317 |
| MNDR | hsa-miR-320a-3p | Ovarian neoplasms | MNDR-E-MI-39318 |
| MNDR | hsa-miR-320a-3p | Kidney cancer | MNDR-E-MI-39319 |
| MNDR | hsa-miR-320a-3p | Glioblastoma | MNDR-E-MI-39320 |
| MNDR | hsa-miR-320a-3p | Astrocytoma | MNDR-E-MI-39321 |
| MNDR | hsa-miR-320a-3p | Glioma | MNDR-E-MI-39322 |
| MNDR | hsa-miR-320a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-39323 |
| MNDR | hsa-miR-320a-3p | Osteosarcoma | MNDR-E-MI-39324 |
| MNDR | hsa-miR-320a-3p | Inclusion body myositis | MNDR-E-MI-39325 |
| MNDR | hsa-miR-320a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39326 |
| MNDR | hsa-miR-320a-3p | Uterus cancer | MNDR-E-MI-39327 |
| MNDR | hsa-miR-320a-3p | Pituitary adenoma | MNDR-E-MI-39328 |
| MNDR | hsa-miR-320a-3p | Lung squamous cell carcinoma | MNDR-E-MI-39329 |
| MNDR | hsa-miR-320a-3p | Non-small cell lung cancer | MNDR-E-MI-39330 |
| MNDR | hsa-miR-320a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-39331 |
| MNDR | hsa-miR-320a-3p | Cholangiocarcinoma | MNDR-E-MI-39332 |
| MNDR | hsa-miR-320a-3p | Esophageal cancer | MNDR-E-MI-39333 |
| MNDR | hsa-miR-320a-3p | Encephalopathy bovine spongiform | MNDR-E-MI-39334 |
| MNDR | hsa-miR-320a-3p | Heart failure | MNDR-E-MI-39335 |
| MNDR | hsa-miR-320a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-39336 |
| MNDR | hsa-miR-320a-3p | Encephalomyelitis | MNDR-E-MI-39337 |
| MNDR | hsa-miR-320a-3p | Leukoencephalopathy progressive multifocal | MNDR-E-MI-39338 |
| MNDR | hsa-miR-320a-3p | Hepatocellular carcinoma | MNDR-E-MI-39339 |
| MNDR | hsa-miR-320a-3p | B-cell lymphoma | MNDR-E-MI-39340 |
| MNDR | hsa-miR-320a-3p | Malignant pleural mesothelioma | MNDR-E-MI-39341 |
| MNDR | hsa-miR-320a-3p | Retinoblastoma | MNDR-E-MI-39342 |
| MNDR | hsa-miR-320a-3p | Neuroblastoma | MNDR-E-MI-39343 |
| MNDR | hsa-miR-320a-3p | Burkitt lymphoma | MNDR-E-MI-39344 |
| MNDR | hsa-miR-320a-3p | Acute myeloid leukemia | MNDR-E-MI-39345 |
| MNDR | hsa-miR-320a-3p | Colorectal cancer | MNDR-E-MI-39346 |
| MNDR | hsa-miR-320a-3p | Multiple myeloma | MNDR-E-MI-39347 |
| MNDR | hsa-miR-320a-3p | Acute lymphocytic leukemia | MNDR-E-MI-39348 |
| MNDR | hsa-miR-320a-3p | Nasopharyngeal cancer | MNDR-E-MI-39349 |
| MNDR | hsa-miR-320a-3p | Nerve degeneration | MNDR-E-MI-39350 |
| MNDR | hsa-miR-320a-3p | Prostatic neoplasms | MNDR-E-MI-39351 |
| MNDR | hsa-miR-320a-3p | Reperfusion injury | MNDR-E-MI-39352 |
| MNDR | hsa-miR-320a-3p | Chronic pain | MNDR-E-MI-39353 |
| MNDR | hsa-miR-320a-3p | Barrett's carcinogenesis | MNDR-E-MI-39354 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG2 | Homo sapiens | RR00024747 |
TOP